News for Enzo Biochem, Inc. (ENZ)

FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (: ENZ) (”œEnzo” or the ”œCompany”) today announced that it was notified by the N

Enzo Biochem notified by NYSE for non-compliance with listing rules.

**media[515140]**

Enzo Biochem Inc. (ENZ) experienced a significant stock movement with a 5.19% increase. The stock is currently valued at $0.750 per share, with a trading volume

**media[493946]**

Enzo Biochem (ENZ) reports first quarter fiscal year 2025 results with non-GAAP EPS of -$0.05 and revenue of $6.21M, down 20.5% year-over-year.

Amgen, Eaton, Sony, iMage and Enzo Biochem are included in this Analyst Blog.

Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc (ETN) and Sony Group Corp. (SONY), as well as two micro-cap stocks, Moving iMage Technologies, Inc. (MITQ) and Enzo Biochem, Inc. (ENZ).

Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031)....

Unlock the future of diagnostics with the Immunohistochemistry market, projected to soar from $3.1 billion in 2023 to $5.5 billion by 2031, growing at a...

The rising prevalence of chronic diseases, increased demand for biologics and biosimilars, and advancements in recombinant protein products are key factors...

Metabolism Assays Market Driven by Increase in Prevalence of Metabolic Disorders...

Microsoft, Ivanti, Virtual Traffic Manager, Admin Access, CryptoCore, Scam, Deepfakes, Avast, Adobe, SAP, BusinessObjects, Build Apps, Paris-Saclay University, Ransomware, BFM TV, Orion, Business…

Westford USA, July 16, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global flow cytometry market will attain a value of USD 6.99 Billion by 2031,...

The dynamics of the inflammatory bowel disease market are anticipated to change in the coming years owing to the improvement in the diagnosis...

The global point-of-care molecular diagnostics market is growing at a CAGR of 13.4% from 2021 to 2028....

Highlights the Destruction of 70% in Stockholder Value Under Garry Mauro’s 10-Year Reign as Chairman Notes the Radoff-Sudbury Group’s Aligned and Highly Qualified Director Candidates...

/PRNewswire/ -- The neurological biomarkers market size is expected to grow by USD 6.92 billion from 2022 to 2027. In addition, the momentum of the market will...

SkyQuest projects that the influenza diagnostics market will attain a USD 1.46 billion value by 2030, with a CAGR of 3.5% over the forecast period...